New data from Commissioning for Quality in Rheumatoid Arthritis (CQRA) shows that implementing commissioning metrics has a significant impact on the quality of services delivered to RA patients and has helped over 70% of patients with RA attain low-disease activity. Implementing these metrics across England will ensure that the 580,000 adults with RA receive quality care and access to treatments at a time when they would be most effective and have the greatest impact on a patient’s condition, minimising the potential for long-term joint damage. The study presented at the British Society of Rheumatology (BSR) Conference found that when CQRA metrics are implemented there is an improvement in patients’ overall disease control. This was measured by DAS28 scores which facilitate routine and intensive monitoring of RA disease in patients, enabling the rapid escalation of treatment to ensure that patients receive optimised therapy leading to a reduction in the impact of RA on their lives and helping them to achieve disease control.